-
Exclusive With Orgenesis CEO: We're Ramping Up The Search For A Diabetes Cure
Monday, March 23, 2015 - 10:29am | 598Read More...The search to find a cure for Type 1 Diabetes has continued with the acquisition of ULB (Universite Libre de Bruxelles) spin-off MaSTherCell by pre-clinical cell therapy and regenerative medicines company Orgenesis Inc (OTC: ORGS) on March 9. Scott Carmer, CEO of Orgenesis North America,...
